Misoprostol versus methylergometrine: Pharmacokinetics in human milk

American Journal of Obstetrics and Gynecology

Volumn 191, Issue 6, 2004, Pages 2168-2173

  Vogel, Danièle ^a   Burkhardt, Tilo ^a   Rentsch, Katharina ^b   Schweer, Horst ^c   Watzer, Bernhard ^c   Zimmermann, Roland ^a   Von Mandach, Ursula ^a,d  

^a Department of Obstetrics ^*  (Switzerland)

^b Institute of Clinical Chemistry   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Human; Lactation; Methylergometrine; Misoprostol; Pharmacokinetics

Indexed keywords

METHYLERGOMETRINE; MISOPROSTOL;

ADULT; ARTICLE; BREAST MILK; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG ELIMINATION; DRUG HALF LIFE; DYSTOCIA; FEMALE; HUMAN; LACTATION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PUERPERIUM; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADULT; BIOLOGICAL AVAILABILITY; BREAST FEEDING; FEMALE; HUMANS; METHYLERGONOVINE; MILK, HUMAN; MISOPROSTOL; OXYTOCICS; POSTPARTUM HEMORRHAGE; PREGNANCY; PROBABILITY; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 10044224341     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2004.05.008     Document Type: Article

References (26)

1. W. Grünberger Postpartum uterus involution and lactation levels in randomized comparison between prostin E2 tablets and methergine dragees [in German] Gynakol Rundsch 23 1983 100 107
2. B. Arabin, H. Rüttgers, and F. Kubli Effects of routine administration of methylergometrin during puerperium on involution, maternal morbidity and lactation [in German] Geburtshilfe Frauenheilkd 46 1986 215 220
3. A.N. de Groot The role of oral (methyl)ergometrine in the prevention of postpartum haemorrhage Eur J Obstet Gynecol Reprod Biol 69 1996 31 36
4. H.V. Hogerzeil, and G.J. Walker Instability of (methyl)ergometrine in tropical climates: an overview Eur J Obstet Gynecol Reprod Biol 69 1996 25 29
5. H. el Refaey, P. O'Brien, W. Morafa, J. Walder, and C. Rodeck Use of oral misoprostol in the prevention of postpartum haemorrhage BJOG 104 1997 336 339
6. R. Mäntylä, T. Kleimola, and J. Kanto Methylergometrine (methylergonovine) concentrations in the human plasma and urine Int J Clin Pharmacol Biopharm 16 1978 254 257
7. A.N. de Groot, T.B. Vree, Y.A. Hekster, M. van den Biggelaar Martea, P.W. van Dongen, and J. van Roosmalen Comparison of the bioavailability and pharmacokinetics of oral methylergometrine in men and women Int J Clin Pharmacol Ther 33 1995 328 332
8. R. Erkkola, J. Kanto, H. Allonen, T. Kleimola, and R. Mantyla Excretion of methylergometrine (methylergonovine) into the human breast milk Int J Clin Pharmacol Biopharm 16 1978 579 580
9. P.A. Arns Misoprostol Am J Med Sci 301 1991 133 137
10. N.M. Davies, J. Longstreth, and F. Jamali Misoprostol therapeutics revisited Pharmacotherapy 21 2001 60 73
11. M. Zieman, S.K. Fong, N.L. Benowitz, D. Banskter, and P.D. Darney Absorption kinetics of misoprostol with oral or vaginal administration Obstet Gynecol 90 1997 88 92
12. K.G. Danielsson, L. Marions, A. Rodriguez, B.W. Spur, P.Y. Wong, and M. Bygdeman Comparison between oral and vaginal administration of misoprostol on uterine contractility Obstet Gynecol 93 1999 275 280
13. A.B. Goldberg, M.B. Greenberg, and P.D. Darney Misoprostol and pregnancy N Engl J Med 344 2001 38 47
14. R.E. Garris, and C.F. Kirkwood Misoprostol: a prostaglandin E1 analogue Clin Pharm 8 1989 627 644
15. H. Abdel-Aleem, J. Villar, M.A. Gülmezoglu, S.A. Mostafa, A.A. Youssef, and M. Shokry The pharmacokinetics of the prostaglandin E1 analogue misoprostol in plasma and colostrum after postpartum oral administration Eur J Obstet Gynecol 108 2003 25 28
16. B. Watzer, H.W. Seyberth, and H. Schweer Determination of misoprostol free acid in human breast milk and serum by gas chromatography/negative ion chemical ionization tandem mass spectrometry J Mass Spectrom 37 2002 927 933
17. O.S. Tang, H. Schweer, H.W. Seyberth, S.W. Lee, and P.C. Ho Pharmacokinetics of different routes of administration of misoprostol Hum Reprod 17 2002 332 336
18. A.A. Bamigboye, D.A. Merrell, G.J. Hofmeyr, and R. Mitchell Randomized comparison of rectal misoprostol with syntometrine for management of third stage of labor Acta Obstet Gynecol Scand 77 1998 178 181
19. H. Abdel Aleem, I. el Nashar, and A. Abdel Aleem Management of severe postpartum hemorrhage with misoprostol Int J Gynaecol Obstet 72 2001 75 76
20. S. Züst, I. Hösli, D. Surbek, and W. Holzgreve Adverse effects of misoprostol in pregnancy [in German] Z Geburtshilfe Neonatol 205 2001 43 48
21. R. Mäntylä, and J. Kanto Clinical pharmacokinetics of methylergometrine (methylergonovine) Int J Clin Pharmacol Ther Toxicol 19 1981 386 391
22. B. Donatini, I. Le Blaye, and P. Krupp Inadvertent administration of uterotonics to neonates Lancet 341 1993 839 840
23. C.R. Baum, P.L. Hilpert, and V.K. Bhutani Accidental administration of an ergot alkaloid to a neonate Pediatrics 98 1996 457 458
24. P.S. Ramsey, B.B. Hogg, K.G. Savage, D.D. Winkler, and J. Owen Cardiovascular effects of intravaginal misoprostol in the mid trimester pregnancy Am J Obstet Gynecol 183 2000 1100 1102
25. F. Amant, B. Spitz, D. Timmerman, A. Corremans, and F.A. Van Assche Misoprostol compared with methylergometrine for the prevention of postpartum haemorrhage: a double-blind randomised trial BJOG 106 1999 1066 1070
26. A.N. de Groot, P.W. van Dongen, T.B. Vree, Y.A. Hekster, and J. van Roosmalen Ergot alkaloids: current status and review of clinical pharmacology and therapeutic use compared with other oxytocics in obstetrics and gynaecology Drugs 56 1998 523 535